| Authors: |
Bossuyt V; Departments of Pathology and Laboratory Medicine, Yale University, New Haven, Connecticut, USA.; Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA., Lau R; Departments of Pathology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.; Health Canada, Ottawa, Ontario., Young B; Darwin/National Foundation for Cancer Research, San Diego, California, USA., Howe JG; Departments of Pathology and Laboratory Medicine, Yale University, New Haven, Connecticut, USA., Zhao F; Department of Data Sciences, Dana Farber Cancer Institute, Harvard University, Boston, Massachusetts, USA., Leyland-Jones B; Darwin/National Foundation for Cancer Research, San Diego, California, USA., Du L; Departments of Pathology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Foli T; Thermo Fisher Scientific, Waltham, Massachusetts, USA., Hatzis C; Departments of Pathology and Laboratory Medicine, Yale University, New Haven, Connecticut, USA., Symmans WF; Departments of Pathology and Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. |
